South africa-founded Healthleap raises $38 million to expand AI disease detection in hospitals. South Africa-founded healthcare technology startup Healthleap has secured $38 million in seed and Series A funding to expand its artificial intelligence platform designed to help hospitals identify patients at risk of undiagnosed medical conditions. The funding comprises an $8 million seed round co-led by Sequoia Capital and First Round Capital, alongside a $30 million Series A round led by Hummingbird Ventures. Founded in 2022 by siblings Jemima and Josiah Meyer, Healthleap develops AI-powered software that examines patients' electronic medical records to identify warning signs of health conditions that healthcare professionals might otherwise overlook. The company's technology analyses clinical notes, laboratory results, vital signs, medication records and other medical information to identify patients who may require additional medical attention. Healthleap initially focused on detecting malnutrition among hospitalised patients before expanding its technology to identify other conditions, including delirium. Unlike systems designed to make medical diagnoses, Healthleap's platform generates risk assessments that help healthcare professionals determine which patients need further evaluation. According to the company, its technology is already being used in more than 50 hospitals, including Penn Medicine, Cedars-Sinai, Houston Methodist and Emory Healthcare. The platform integrates with existing hospital electronic health record systems, allowing medical teams to review patient risk information within their normal workflows. Healthleap says its technology can also help hospitals improve operational efficiency by identifying medical concerns earlier, potentially reducing complications and unnecessary hospital stays. The company reported significant growth in hospital partnerships over the past year, reflecting increasing interest in artificial intelligence applications within healthcare. Healthleap plans to use the newly secured capital to expand its engineering, product development, sales and customer support teams. The startup also intends to broaden its technology to identify more than 40 major medical conditions, with longer-term ambitions to expand into outpatient and home-based healthcare. The investment highlights growing investor interest in AI-powered healthcare solutions that support clinical decision-making and address challenges faced by overstretched medical professionals. For Africa's technology ecosystem, Healthleap's growth also demonstrates the potential for startups founded on the continent to develop healthcare innovations capable of serving international markets.

Healthleap raises $38M to power AI that flags at-risk hospital patients. Tl;dr. * Healthleap has raised $38M in total funding, including an $8M seed round co-led by Sequoia Capital and First Round Capital and a $30M Series A led by Hummingbird Ventures. * Its AI platform integrates with hospital EHRs to continuously scan vitals, labs, and clinical notes to flag patients at risk of deterioration hours earlier than traditional methods. * The new capital will be used to expand hospital deployments across the U.S., grow its clinical and engineering teams, and pursue additional FDA clearances. The patient no one noticed. Every hospital has the same story. A patient looks stable on morning rounds, then crashes in the afternoon. The warning signs were there - a subtle drift in blood pressure, a missed lab trend, a nurse's note buried in the chart - but no one connected the dots in time. Healthleap, a New York and Tel Aviv-based health AI startup, is building technology to catch those moments. Its platform sits on top of existing electronic health records and acts as a continuous safety layer, scanning real-time data streams to surface patients who may need a closer look before they become emergencies. The company announced on October 7, 2026 that it has secured $38M in total funding to scale that vision. How Healthleap's AI actually works. Unlike predictive tools that fire off constant, noisy alerts, Healthleap says it focused on clinical trust from day one. The system pulls together vitals, lab results, medications, and free-text clinical notes, then uses large language models combined with clinical risk models to prioritize the highest-risk patients for rapid response teams and bedside nurses. Instead of a score that clinicians have to interpret, it delivers an explainable summary: why this patient was flagged, what changed in the last few hours, and what to check next. Hospital partners say that workflow-first design is key to reducing alarm fatigue, a major reason past AI monitoring tools failed to stick. Early deployments have focused on general medical-surgical floors and step-down units, where patient-to-nurse ratios are high and deterioration is easiest to miss. The company says its customers have seen earlier sepsis detection, faster ICU transfers when needed, and fewer code blue events. Why Sequoia, First Round and Hummingbird are backing it. The funding story itself signals strong conviction. Healthleap raised an $8M seed round co-led by Sequoia Capital and First Round Capital, then followed quickly with a $30M Series A led by Hummingbird Ventures, bringing total funding to $38M. Investors point to three factors: timing, team, and traction. Hospitals are under intense pressure from staffing shortages, rising acuity, and a shift to value-based care that penalizes preventable harm. At the same time, health systems are finally moving EHR data to the cloud, making real-time AI deployment feasible. Sequoia and First Round backed the company at seed for its technical approach to messy clinical data. Hummingbird led the Series A to help scale go-to-market in the U.S. and Europe, where demand for AI-driven patient safety tools has surged following new regulatory clarity around clinical decision support. What the $38M means for hospitals. Healthleap says the Series A capital will be used to triple its headcount across engineering, clinical science, and customer deployment, and to expand from a handful of flagship health system partners to dozens of hospitals over the next 18 months. A major priority is validation and clearance. The startup plans to pursue additional FDA clearances, publish peer-reviewed outcomes data, and deepen integrations with Epic and Oracle Health so implementation takes weeks, not months. The funds will also go toward new modules beyond deterioration detection, including AI support for discharge readiness, hospital capacity management, and documentation that helps overworked nurses spend less time in front of a screen. The bigger bet on the future of hospital care. Healthleap's raise is part of a broader wave of AI investment moving from back-office automation to bedside care. Investors are no longer just funding AI that writes clinical notes - they want AI that helps decide who needs attention right now. If the technology delivers at scale, it could reshape how hospitals think about safety: from reactive rapid response to proactive, AI-assisted surveillance where every patient is continuously watched, even when staff can't be in the room. Challenges remain, including rigorous clinical trials, equity audits to ensure models work across populations, and earning frontline trust. But with $38M in fresh backing and some of tech's most prominent investors on its cap table, Healthleap has become one of the startups to watch in the race to make hospitals safer with AI. AndroGuider Team Articles written by the AndroGuider team. Androguider try to make them thorough and informational while being easy to read.